Skip to content
2000
Volume 9, Issue 4
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The development of a vaccine for cancer has been difficult compared to the effective vaccines of infectious diseases. Most tumor antigens are not entirely foreign and are expressed on normal tissues, thus, making it difficult to induce strong immune responses against self antigens. A peptide mimic, however, may have the potential to generate greater immune responses than those induced to self peptides. In this review we discuss applications of peptide mimcs for cancer immunotherapy which may ultimately prove useful in humans.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867023370969
2002-02-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867023370969
Loading

  • Article Type:
    Review Article
Keyword(s): anti-idiotypic antibodies; immunotherapy; lipooligosaccharide; Peptide Mimetics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test